Lundbeckfonden Ventures is an evergreen life science venture capital firm in Copenhagen that invests in early and late stage ventures. Established in the autumn of 2009 and wholly owned by Lundbeck Foundation, it offers flexible and long-term investments. It typically invests in Series B, Series A, Series C, and in post-IPO equity. Its portfolio companies include Spero Therapeutics, SANIFIT, Reneo Pharmaceuticals, Aura Biosciences, River Vision Development, Vtesse, Ziarco, Celladon and Asante Solutions.
Since 2009, the company has invested in 31 life science companies in the US and Europe, and have an active portfolio of about 20 companies representing a wide range of therapeutic areas. It invests around DKK 350 to 400 million annually.
A pharmaceutical company developing tissue factor therapies for the treatment of cancer and diseases.
A company developing drugs for orphan and rare diseases
A biopharmaceutical company developing drugs for the treatment of chronic inflammatory diseases
A biopharmaceutical company developing therapeutics for skin disorders
A company that develops cell therapies to treat kidney diseases
scPharmaceuticals is a Burlington, Massachusetts-based company.
Vice President Finance
Mette Kirstine Agger
Documentaries, videos and podcasts